Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siva Sai Krishna Dasa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|November 21, 2012
Target-specific copper hybrid T7 phage particlesSiva Sai Krishna Dasa, Qiaoling Jin, Chin-Tu Chen, et al.
Plos One|May 18, 2016
PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation SequencingLindsey T Brinton, Dustin K Bauknight, Siva Sai Krishna Dasa, et al.
Biomolecules|December 24, 2021
Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the PancreasJill P Smith, Hong Cao, Elijah F Edmondson, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 25, 2020
Challenges in the development of nanoparticle-based imaging agents: Characterization and biologyRachael M Crist, Siva Sai Krishna Dasa, Christina H Liu, et al.
International Journal of Molecular Sciences|January 8, 2023
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant <i>Kras</i> to Prevent Pancreatic Carcinogenesis and Halt Tumor ProgressionJill P Smith, Wenqiang Chen, Narayan Shivapurkar, et al.
Theranostics|May 19, 2018
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancerSiva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2015
Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarctionSiva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2017
Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugsSiva Sai Krishna Dasa, Ryo Suzuki, Emily Mugler, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal AdenocarcinomaJessica Hung, Samantha M Perez, Siva Sai Krishna Dasa, et al.
Plos One|November 15, 2019
Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effectsDustin K Bauknight, Victoria Osinski, Siva Sai Krishna Dasa, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Langmuir : the ACS Journal of Surfaces and Colloids|November 21, 2012
Target-specific copper hybrid T7 phage particlesSiva Sai Krishna Dasa, Qiaoling Jin, Chin-Tu Chen, et al.
Plos One|May 18, 2016
PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation SequencingLindsey T Brinton, Dustin K Bauknight, Siva Sai Krishna Dasa, et al.
Biomolecules|December 24, 2021
Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the PancreasJill P Smith, Hong Cao, Elijah F Edmondson, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 25, 2020
Challenges in the development of nanoparticle-based imaging agents: Characterization and biologyRachael M Crist, Siva Sai Krishna Dasa, Christina H Liu, et al.
International Journal of Molecular Sciences|January 8, 2023
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant <i>Kras</i> to Prevent Pancreatic Carcinogenesis and Halt Tumor ProgressionJill P Smith, Wenqiang Chen, Narayan Shivapurkar, et al.
Theranostics|May 19, 2018
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancerSiva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2015
Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarctionSiva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2017
Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugsSiva Sai Krishna Dasa, Ryo Suzuki, Emily Mugler, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal AdenocarcinomaJessica Hung, Samantha M Perez, Siva Sai Krishna Dasa, et al.
Plos One|November 15, 2019
Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effectsDustin K Bauknight, Victoria Osinski, Siva Sai Krishna Dasa, et al.
Pageof 2